Adham, I. M., Burkhardt, E., Benahmed, M., & Engel, W. (1993). Cloning of a cDNA for a novel insulin-like peptide of the testicular Leydig cells. J Biol Chem, 268(35), 26668-26672.
Ahmed, M. S., Gravning, J., Martinov, V. N., von Lueder, T. G., Edvardsen, T., Czibik, G., . . . Attramadal, H. (2011). Mechanisms of novel cardioprotective functions of CCN2/CTGF in myocardial ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol, 300(4), H1291-1302. doi:
https://doi.org/10.1152/ajpheart.00604.2010
Alleva, D. G., Kaser, S. B., Monroy, M. A., Fenton, M. J., & Beller, D. I. (1997). IL-15 functions as a potent autocrine regulator of macrophage proinflammatory cytokine production: evidence for differential receptor subunit utilization associated with stimulation or inhibition. J Immunol, 159(6), 2941-2951.
Aoi, W., Naito, Y., Hang, L. P., Uchiyama, K., Akagiri, S., Mizushima, K., & Yoshikawa, T. (2011). Regular exercise prevents high-sucrose diet-induced fatty liver via improvement of hepatic lipid metabolism. Biochem Biophys Res Commun, 413(2), 330-335. doi:
https://doi.org/10.1016/j.bbrc.2011.08.097
Baccari, M. C., Bani, D., Bigazzi, M., & Calamai, F. (2004). Influence of relaxin on the neurally induced relaxant responses of the mouse gastric fundus. Biol Reprod, 71(4), 1325-1329. doi:
https://doi.org/10.1095/biolreprod.104.029579
Baccari, M. C., Nistri, S., Vannucchi, M. G., Calamai, F., & Bani, D. (2007). Reversal by relaxin of altered ileal spontaneous contractions in dystrophic (mdx) mice through a nitric oxide-mediated mechanism. Am J Physiol Regul Integr Comp Physiol, 293(2), R662-668. doi:
https://doi.org/10.1152/ajpregu.00214.2007
Banerjee, A., Shen, P. J., Ma, S., Bathgate, R. A., & Gundlach, A. L. (2010). Swim stress excitation of nucleus incertus and rapid induction of relaxin-3 expression via CRF1 activation. Neuropharmacology, 58(1), 145-155. doi:
https://doi.org/10.1016/j.neuropharm.2009.06.019
Bani-Sacchi, T., Bigazzi, M., Bani, D., Mannaioni, P. F., & Masini, E. (1995). Relaxin-induced increased coronary flow through stimulation of nitric oxide production. Br J Pharmacol, 116(1), 1589-1594. doi:
https://doi.org/10.1111/j.1476-5381.1995.tb16377.x
Bathgate, R. A., Halls, M. L., van der Westhuizen, E. T., Callander, G. E., Kocan, M., & Summers, R. J. (2013). Relaxin family peptides and their receptors. Physiol Rev, 93(1), 405-480. doi:
https://doi.org/10.1152/physrev.00001.2012
Bryant-Greenwood, G. D., Rutanen, E. M., Partanen, S., Coelho, T. K., & Yamamoto, S. Y. (1993). Sequential appearance of relaxin, prolactin and IGFBP-1 during growth and differentiation of the human endometrium. Mol Cell Endocrinol, 95(1-2), 23-29. doi:
https://doi.org/10.1016/0303-7207(93)90025-f
Chaqour, B. (2020). Caught between a "Rho" and a hard place: are CCN1/CYR61 and CCN2/CTGF the arbiters of microvascular stiffness? J Cell Commun Signal, 14(1), 21-29. doi:
https://doi.org/10.1007/s12079-019-00529-3
Chen, M. M., Lam, A., Abraham, J. A., Schreiner, G. F., & Joly, A. H. (2000). CTGF expression is induced by TGF- beta in cardiac fibroblasts and cardiac myocytes: a potential role in heart fibrosis. J Mol Cell Cardiol, 32(10), 1805-1819. doi:
https://doi.org/10.1006/jmcc.2000.1215
Danielson, L. A., Kercher, L. J., & Conrad, K. P. (2000). Impact of gender and endothelin on renal vasodilation and hyperfiltration induced by relaxin in conscious rats. Am J Physiol Regul Integr Comp Physiol, 279(4), R1298-1304. doi:
https://doi.org/10.1152/ajpregu.2000.279.4.R1298
Deswal, A., Petersen, N. J., Feldman, A. M., Young, J. B., White, B. G., & Mann, D. L. (2001). Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST). Circulation, 103(16), 2055-2059. doi:
https://doi.org/10.1161/01.cir.103.16.2055
Faienza, M. F., Chiarito, M., Molina-Molina, E., Shanmugam, H., Lammert, F., Krawczyk, M., . . . Portincasa, P. (2020). Childhood obesity, cardiovascular and liver health: a growing epidemic with age. World Journal of Pediatrics, 16(5), 438-445. doi:
https://doi.org/10.1007/s12519-020-00341-9
Gaudio, E., Nobili, V., Franchitto, A., Onori, P., & Carpino, G. (2012). Nonalcoholic fatty liver disease and atherosclerosis. Intern Emerg Med, 7 Suppl 3, S297-305. doi:
https://doi.org/10.1007/s11739-012-0826-5
Gillen, J. B., & Gibala, M. J. (2014). Is high-intensity interval training a time-efficient exercise strategy to improve health and fitness? Appl Physiol Nutr Metab, 39(3), 409-412. doi:
https://doi.org/10.1139/apnm-2013-0187
Gressner, O. A., Lahme, B., Demirci, I., Gressner, A. M., & Weiskirchen, R. (2007). Differential effects of TGF-beta on connective tissue growth factor (CTGF/CCN2) expression in hepatic stellate cells and hepatocytes. J Hepatol, 47(5), 699-710.
https://doi.org/10.1016/j.jhep.2007.05.015
Guo-qiang, Y., Yong-sheng, Q., & Peng, P. (2020). The effect and mechanism of aerobic training on cardiac fibrosis in spontaneously hypertensive rats. Tianjin Medicin Journal, Vol. 48 (2), 100-104. doi:
http://eprints.soton.ac.uk/67633/
Heeg, M. H., Koziolek, M. J., Vasko, R., Schaefer, L., Sharma, K., Müller, G. A., & Strutz, F. (2005). The antifibrotic effects of relaxin in human renal fibroblasts are mediated in part by inhibition of the Smad2 pathway. Kidney Int, 68(1), 96-109. doi:
https://doi.org/10.1111/j.1523-1755.2005.00384.x
Heringlake, M., Kox, T., Poeling, J., Klaus, S., Hanke, T., Franz, N., . . . Bahlmann, L. (2009). The effects of physical exercise on plasma levels of relaxin, NTproANP, and NTproBNP in patients with ischemic heart disease. Eur J Med Res, 14(3), 106-112. doi:
https://doi.org/10.1186/2047-783x-14-3-106
Jamali, R., Khonsari, M., Merat, S., Khoshnia, M., Jafari, E., Bahram Kalhori, A., . . . Pourshams, A. (2008). Persistent alanine aminotransferase elevation among the general Iranian population: prevalence and causes. World J Gastroenterol, 14(18), 2867-2871. doi:
https://doi.org/10.3748/wjg.14.2867
Jones, A. M., Krustrup, P., Wilkerson, D. P., Berger, N. J., Calbet, J. A., & Bangsbo, J. (2012). Influence of exercise intensity on skeletal muscle blood flow, O2 extraction and O2 uptake on-kinetics. J Physiol, 590(17), 4363-4376. doi:
https://doi.org/10.1113/jphysiol.2012.233064
Keating, S. E., Hackett, D. A., George, J., & Johnson, N. A. (2012). Exercise and non-alcoholic fatty liver disease: a systematic review and meta-analysis. J Hepatol, 57(1), 157-166. doi:
https://doi.org/10.1016/j.jhep.2012.02.023
Krüger, S., Graf, J., Merx, M. W., Stickel, T., Kunz, D., Hanrath, P., & Janssens, U. (2004). Relaxin kinetics during dynamic exercise in patients with chronic heart failure. Eur J Intern Med, 15(1), 54-56. doi:
https://doi.org/10.1016/j.ejim.2003.11.009
Laursen, P. B., & Jenkins, D. G. (2002). The scientific basis for high-intensity interval training: optimising training programmes and maximising performance in highly trained endurance athletes. Sports Med, 32(1), 53-73. doi:
https://doi.org/10.2165/00007256-200232010-00003
Lee, K. C., Hsieh, Y. C., Chan, C. C., Sun, H. J., Huang, Y. H., Hou, M. C., & Lin, H. C. (2019). Human relaxin-2 attenuates hepatic steatosis and fibrosis in mice with non-alcoholic fatty liver disease. Lab Invest, 99(8), 1203-1216. doi:
https://doi.org/10.1038/s41374-019-0240-y
Nistri, S., Chiappini, L., Sassoli, C., & Bani, D. (2003). Relaxin inhibits lipopolysaccharide-induced adhesion of neutrophils to coronary endothelial cells by a nitric oxide-mediated mechanism. FASEB J, 17(14), 2109-2111. doi:
https://doi.org/10.1096/fj.03-0216fje
Richter, E. A., & Ruderman, N. B. (2009). AMPK and the biochemistry of exercise: implications for human health and disease. Biochem J, 418(2), 261-275. doi:
https://doi.org/10.1042/bj20082055
Roozbayani, M., Peeri, M., Agha-Alinejad, H., & Azarbayjani, M. A. (2016). Effect of Continues Training and High Intensity Interval Training on miR-29a and CTGF Gene Expression in Male Wistar Diabetic Rats’ Heart Tissue [Research]. Iranian Journal of Diabetes and Obesity, 8(3), 142-150. doi:
http://ijdo.ssu.ac.ir/article-1-310-en.html
Ruiz, J. R., Labayen, I., Ortega, F. B., Moreno, L. A., Rodriguez, G., Breidenassel, C., . . . Sjöström, M. (2014). Physical activity, sedentary time, and liver enzymes in adolescents: the HELENA study. Pediatr Res, 75(6), 798-802. doi:
https://doi.org/10.1038/pr.2014.26
Samuel, C. S., Unemori, E. N., Mookerjee, I., Bathgate, R. A., Layfield, S. L., Mak, J., . . . Du, X. J. (2004). Relaxin modulates cardiac fibroblast proliferation, differentiation, and collagen production and reverses cardiac fibrosis in vivo. Endocrinology, 145(9), 4125-4133. doi:
https://doi.org/10.1210/en.2004-0209
Sarwar, M., Du, X. J., Dschietzig, T. B., & Summers, R. J. (2017). The actions of relaxin on the human cardiovascular system. Br J Pharmacol, 174(10), 933-949. doi:
https://doi.org/10.1111/bph.13523
Schreckenberg, R., Horn, A. M., da Costa Rebelo, R. M., Simsekyilmaz, S., Niemann, B., Li, L., . . . Schlüter, K. D. (2017). Effects of 6-months' Exercise on Cardiac Function, Structure and Metabolism in Female Hypertensive Rats-The Decisive Role of Lysyl Oxidase and Collagen III. Front Physiol, 8, 556. doi:
https://doi.org/10.3389/fphys.2017.00556
Sciarretta, S., Paneni, F., Palano, F., Chin, D., Tocci, G., Rubattu, S., & Volpe, M. (2009). Role of the renin-angiotensin-aldosterone system and inflammatory processes in the development and progression of diastolic dysfunction. Clin Sci (Lond), 116(6), 467-477. doi:
https://doi.org/10.1042/cs20080390
Shi-Wen, X., Leask, A., & Abraham, D. (2008). Regulation and function of connective tissue growth factor/CCN2 in tissue repair, scarring and fibrosis. Cytokine Growth Factor Rev, 19(2), 133-144. doi:
https://doi.org/10.1016/j.cytogfr.2008.01.002
Sookoian, S., & Pirola, C. J. (2008). Non-alcoholic fatty liver disease is
Szabó, Z., Magga, J., Alakoski, T., Ulvila, J., Piuhola, J., Vainio, L., . . Kerkelä, R. (2014). Connective tissue growth factor inhibition attenuates left ventricular remodeling and dysfunction in pressure overload-induced heart failure. Hypertension, 63(6), 1235-1240. doi:
https://doi.org/10.1161/hypertensionaha.114.03279
Tahereh Fakharian, Shima Heydari, Ghodsiyeh Azarkar, & bakhsh, A. r. E. (2017). The role of non- alcoholic fatty liver disease (NAFLD)in the occurrence of CVDs through measuring carotid intima-media thickness. Birjand University of Medical Sciences, 24(1), 63-72. ten Dijke, P., & Arthur, H. M. (2007). Extracellular control of TGFbeta signalling in vascular development and disease. Nat Rev Mol Cell Biol, 8(11), 857-869. doi:
https://doi.org/10.1038/nrm2262
Thoma, C., Day, C. P., & Trenell, M. I. (2012). Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: a systematic review. J Hepatol, 56(1), 255-266. doi:
https://doi.org/10.1016/j.jhep.2011.06.010
Tong, Z., Chen, R., Alt, D. S., Kemper, S., Perbal, B., & Brigstock, D. R. (2009). Susceptibility to liver fibrosis in mice expressing a connective tissue growth factor transgene in hepatocytes. Hepatology, 50(3), 939-947. doi:
https://doi.org/10.1002/hep.23102
Villegas, R., Xiang, Y. B., Elasy, T., Cai, Q., Xu, W., Li, H., . . . Shu, X. O. (2011). Liver enzymes, type 2 diabetes, and metabolic syndrome in middle-aged, urban Chinese men. Metab Syndr Relat Disord, 9(4), 305-311. doi:
https://doi.org/10.1089/met.2011.0016
Wahab, N. A., Yevdokimova, N., Weston, B. S., Roberts, T., Li, X. J., Brinkman, H., & Mason, R. M. (2001). Role of connective tissue growth factor in the pathogenesis of diabetic nephropathy. Biochem J, 359(Pt 1), 77-87. doi:
https://doi.org/10.1042/0264-6021:3590077
Wang, S. Q., Li, D., & Yuan, Y. (2019). Long-term moderate intensity exercise alleviates myocardial fibrosis in type 2 diabetic rats via inhibitions of oxidative stress and TGF-β1/Smad pathway. J Physiol Sci, 69(6), 861-873. doi:
https://doi.org/10.1007/s12576-019-00696-3
Wu, C. K., Wang, Y. C., Lee, J. K., Chang, S. N., Su, M. Y., Yeh, H. M., . . . Tsai, C. T. (2014). Connective tissue growth factor and cardiac diastolic dysfunction: human data from the Taiwan diastolic heart failure registry and molecular basis by cellular and animal models. Eur J Heart Fail, 16(2), 163-172. doi:
https://doi.org/10.1002/ejhf.33
Yang, H. L., Hsieh, P. L., Hung, C. H., Cheng, H. C., Chou, W. C., Chu, P. M., . . . Tsai, K. L. (2020). Early Moderate Intensity Aerobic Exercise Intervention Prevents Doxorubicin-Caused Cardiac Dysfunction Through Inhibition of Cardiac Fibrosis and Inflammation. Cancers (Basel), 12(5). doi:
https://doi.org/10.3390/cancers12051102